Ajit Ramalingam - 10 Nov 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
SVP, Chief Accounting Officer
Signature
/s/ Ajit Ramalingam
Issuer symbol
BIO
Transactions as of
10 Nov 2022
Net transactions value
-$160,051
Form type
4
Filing time
14 Nov 2022, 15:33:54 UTC
Previous filing
07 Sep 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Sale $112,594 -267 -70% $421.70 112 10 Nov 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Sale $47,295 -112 -100% $422.28 0 10 Nov 2022 Direct
transaction BIO Bio-Rad A Common Stock Sale $161 -0 -100% $423.61 0 10 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.47 to $421.94, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Includes 13.884 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.